e-learning
resources
Munich 2014
Monday, 08.09.2014
Pulmonary hypertension in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between antiphospholipid antibody type and level and pulmonary manifestations in APS
M. Kontic, L. Stojanovic, A. Djokic, N. Ilijevski (Belgrade, Republic Of Serbia)
Source:
International Congress 2014 – Pulmonary hypertension in lung disease
Session:
Pulmonary hypertension in lung disease
Session type:
Thematic Poster Session
Number:
2346
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kontic, L. Stojanovic, A. Djokic, N. Ilijevski (Belgrade, Republic Of Serbia). Association between antiphospholipid antibody type and level and pulmonary manifestations in APS. Eur Respir J 2014; 44: Suppl. 58, 2346
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The definition of pulmonary hypertension: history, practical implications and current controversies
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Related content which might interest you:
Clinical phenotypes in pulmonary emboli identified by cluster analysis
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Isolated hypocapnia: A sign not to be neglected
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Serum apelin 13 levels in patients with pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Alteration of factors associated with coagulation in provoked pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Warfarin-associated intracranial hemorrhage during anticoagulation therapy
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Do persistent perfusion defects predict late recurrences in pulmonary embolism?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Endothelial-to-mesenchymal transition in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Improving the safety of right heart catheterisation in sickle cell disease
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Chronic thromboembolic vasculopathy with exercise induced PH but normal resting haemodynamics
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
An overview of thrombolytic treatment for pulmonary embolism: A single center experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Long-term screening for pulmonary hypertension after pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Smad1 deficiency and female gender contribute to the development of pulmonary hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept